Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.

about

Standing in the Shifting Sands of Molecular Targeting and Precision Medicine Is the Oasis of 21st-Century Oncology Therapeutics.

P2860

Q50045474-5CF5114A-82AD-4FF4-910D-625B620DA1A2

P2860

Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.

Item

http://www.wikidata.org/entity/Q47568807

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.

@en

Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.

@nl

type

Item

label

Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.

@en

Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.

@nl

prefLabel

Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.

@en

Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.

@nl

P1476

Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.

@en

P2093

Heather E Vezina

http://www.w3.org/2001/XMLSchema#string

Manish Gupta

http://www.w3.org/2001/XMLSchema#string

Monette Cotreau

http://www.w3.org/2001/XMLSchema#string

Tae H Han

http://www.w3.org/2001/XMLSchema#string

P2860

Synthesis of site-specific antibody-drug conjugates using unnatural amino acids

Recent Advances in Development and Application of Physiologically-Based Pharmacokinetic (PBPK) Models: a Transition from Academic Curiosity to Regulatory Acceptance

New developments for antibody-drug conjugate-based therapeutic approaches

Antibody-drug conjugates--an emerging class of cancer treatment

Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics

Antibody-drug conjugates as novel anti-cancer chemotherapeutics

Comparative clinical pharmacokinetics of antibody-drug conjugates in first-in-human Phase 1 studies

Trastuzumab emtansine: a unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancer

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Clinical Advancements in the Targeted Therapies against Liver Fibrosis.

P304

S11-S25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.981

http://www.w3.org/2001/XMLSchema#string

P478

57 Suppl 10

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28921650

http://www.w3.org/2001/XMLSchema#string

Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.

about

P2860

P2860

Antibody-Drug Conjugates as Cancer Therapeutics: Past, Present, and Future.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698